Early effect on general interest, and short-term antidepressant efficacy and safety of agomelatine (25–50mg/day) and escitalopram (10–20mg/day) in outpatients with Major Depressive Disorder. A 12-week randomised double-blind comparative study - Microorganismes, Molécules Bioactives et Physiopathologie Intestinale Accéder directement au contenu
Article Dans Une Revue Journal of Affective Disorders Année : 2016

Early effect on general interest, and short-term antidepressant efficacy and safety of agomelatine (25–50mg/day) and escitalopram (10–20mg/day) in outpatients with Major Depressive Disorder. A 12-week randomised double-blind comparative study

T. Udristoiu
  • Fonction : Auteur
P. Dehelean
  • Fonction : Auteur
V. Raba
  • Fonction : Auteur
F. Picarel-Blanchot
  • Fonction : Auteur
C. de Bodinat
  • Fonction : Auteur

Domaines

Chimie organique
Fichier non déposé

Dates et versions

hal-01302534 , version 1 (14-04-2016)

Identifiants

Citer

T. Udristoiu, P. Dehelean, Ph Nuss, V. Raba, F. Picarel-Blanchot, et al.. Early effect on general interest, and short-term antidepressant efficacy and safety of agomelatine (25–50mg/day) and escitalopram (10–20mg/day) in outpatients with Major Depressive Disorder. A 12-week randomised double-blind comparative study. Journal of Affective Disorders, 2016, 199, pp. 6-12. ⟨10.1016/j.jad.2016.03.048⟩. ⟨hal-01302534⟩
66 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More